#Healthcare
Explore articles tagged with Healthcare
GLP-1 Patent Expiry 2026: A Defining Opportunity for Indian Pharma
HRV Pharma's CEO Hari Kiran Chereddi analyzes India's strategic opportunity in GLP-1 drug manufacturing as Semaglutide patents expire in 2026, emphasizing the shift from reverse engineering to innovative design.
The US Drug Pricing Shock: A Mandate for Recalibration, Not Reaction
HRV Pharma's CEO Hari Kiran Chereddi outlines strategic recalibration approach to US drug pricing policies, emphasizing global diversification and value-based transformation over reactive market responses.
Express Pharma June 2025 Feature : The New Rules of Pharma
HRV Pharma is redefining pharmaceutical manufacturing through distributed orchestration, compliance-driven models, and technology-first strategies to build resilient, globally connected supply chains for the future.
Life Sciences Sector Maximizes Advanced Technology Adoption
HRV Pharma's leadership shares insights on National Technology Day 2025, highlighting how AI, machine learning, and digital technologies are revolutionizing healthcare delivery and pharmaceutical innovation
Trump's MFN Executive Order Strengthens Generic and Biosimilar Adoption
Analysis of President Trump's Most Favored Nation executive order impact on generic and biosimilar markets, with HRV Pharma's strategic insights on opportunities for Indian pharmaceutical manufacturers
Lifesciences Sector Maximizes Adoption of Advanced Technologies to Unlock New Possibilities
HRV Pharma is reshaping pharmaceutical manufacturing through compliance-first strategies, distributed orchestration, and technology-driven innovation, as featured in Express Pharma’s June 2025 edition.
Market Momentum: Dynamic Drivers of Pharmaceutical Growth
Comprehensive analysis of key forces driving pharmaceutical industry transformation, from biotech advances and AI-powered drug discovery to emerging markets and virtual pharma models reshaping global healthcare.
Pharma 4.0: Smart Manufacturing Redefining Generic Drug Production
Explore how AI, automation, and real-time analytics are transforming generic drug production through smart manufacturing and continuous processes.
India's Strategic Role in the Global Medtech Reset: Navigating US Tariffs
Our CEO Hari Kiran Chereddi shares insights in Citeline Medtech Insight on India's role in global supply chains amidst US medical device tariffs.
Green Pharma 2.0: AI and Digital Twins Revolutionizing Indian Pharmaceutical Manufacturing
HRV pharma's Hari Kiran Chereddi discusses AI, digital twins, and sustainable molecule design transforming Indian pharmaceutical manufacturing.
US Tariff Relief for Indian Pharma: A Strategic Opportunity for Growth?
Discover how Indian pharma can leverage US tariff relief to strengthen partnerships, innovate, and maintain global competitiveness in healthcare affordability.
India's API Industry at a Key Juncture: Navigating Global Supply Chain Dynamics
HRV Pharma's Sreenivas Varma discusses India's API industry transformation, PLI schemes, and the shift towards high-value pharmaceutical manufacturing.
US Tariffs: An Opportunity for Indian Pharma to Reinvent Itself
The possibility of increased US tariffs has sparked concerns within the Indian pharmaceutical sector. However, instead of viewing this as a setback, it's time to consider it a catalyst for strategic reinvention and growth.
HRV Pharma Strengthens Global Presence at DCAT Week 2025 in New York
HRV Pharma makes significant strides in global pharmaceutical partnerships during DCAT Week 2025 in New York, showcasing innovation and expanding its international footprint.
How Indian Pharma is Preparing to Mitigate US Tariff Challenges
HRV Pharma's leadership discusses strategic approaches for Indian pharmaceutical companies to navigate potential US tariff challenges while maintaining global competitiveness and healthcare affordability.
Pharma Leveraging AI: Transforming the Future of Drug Development
The pharmaceutical industry is undergoing a revolution, powered by Artificial Intelligence (AI). As highlighted in a recent article, AI is transforming drug discovery, clinical trials, disease diagnosis, and manufacturing processes.
Indian Pharma's Strategic US Expansion: Insights from Hari Kiran Chereddi
Hari Kiran Chereddi shares strategic insights on Indian pharma’s US expansion via acquisitions, regulatory agility, and supply chain resilience in a competitive market.
Union Budget 2025-26: A Transformative Leap for India’s Healthcare Sector
Our CEO Mr. Hari Chereddi, applauds the government's decision to exempt Basic Customs Duty on 36 life-saving drugs, highlighting the positive impact on patient accessibility and affordability
HRV Pharma Eyes Strategic Expansion into Sri Lankan Pharmaceutical Market
HRV Pharma has announced its strategic interest in expanding operations into Sri Lanka, positioning the island nation as a key growth market in the company's South Asian expansion strategy.
Hari Kiran Chereddi Featured in Exclusive CPhI Milan Interview
HRV’s CEO discusses virtual pharma models and navigating complex global markets in a CPhI Milan interview, emphasizing innovation and regulatory mastery.
CNN Business Arabic has featured HRV Global Life Sciences
CNN Business Arabic highlights HRV Global's resilient supply chain strategies and ambitious Middle East expansion plans, showcasing success in complex markets including Iran, Iraq, and UAE.
HRV Pharma Honored with Dual Leadership Awards for Excellence in India and Middle East Markets
HRV Pharma has been honored with two prestigious leadership awards, recognizing the company as a leading pharmaceutical enterprise in both India and the Middle East markets